News Archive

NEWS ARCHIVE

Explore our archive of news and updates from the HS Foundation — a curated collection of stories, milestones, and announcements from over the years.

Alexa Kimball, MD, on the Future of HS Care

October 22, 2025

Dr. Alexa Kimball shares insights on the future of hidradenitis suppurativa care — from earlier diagnosis and better treatment strategies to integrating comorbidities into research. She also explores emerging therapies like GLP-1 receptor agonists and what’s next for advancing HS management.
Read more

Recognizing HS: From First Signs to an Accurate Diagnosis

October 16, 2025

Hidradenitis suppurativa is often misunderstood and underdiagnosed—even though its telltale signs can emerge early. Explore how key symptoms like painful nodules, abscesses, and draining tunnels can offer a pathway to timely diagnosis and more compassionate, effective care.
Read more

Beyond the Surface: October 2025

October 10, 2025

This month’s newsletter features exciting updates on the new HS Buddy Program, details for SHSA 2025 in Nashville, current grant opportunities, and the latest HS in the News. Don’t miss what’s happening in the HS community — check it out now!
Read more

Can Quitting Smoking Lower the Risk of Hidradenitis Suppurativa?

September 29, 2025

A new study of more than 6 million people shows that quitting smoking can cut the risk of hidradenitis suppurativa by about one-third—but the benefits appear only after staying smoke-free for at least three years. Relapsing, however, brings the risk right back up.
Read more

HS Summit Spotlights Gaps in Diagnosis and Care

September 11, 2025

The summit highlighted the challenges of diagnosing HS, emphasizing the need for awareness & recognizing chronic, recurrent patterns. Patient storytelling & joint panels underscored the real-world burden of HS & the importance of early intervention. Collaboration between patients & providers is crucial for improving outcomes & raising the standard of care in HS management.
Read more

HS Foundation Launches New HS Buddy Program to Support Clinical Trial Participants

July 29, 2025

The HS Buddy Program is a peer support initiative designed to connect individuals currently in or considering a clinical trial with experienced "buddies" who can offer guidance, share personal insights, and help navigate the clinical trial journey. Learn how you can get involved as a participant or a peer mentor.
Read more

From the Heart: July 2025

July 17, 2025

In this issue: We're celebrating 20 years of advancing care, research, and support for those impacted by Hidradenitis Suppurativa. Catch up on recent news in the HS world, important updates for SHSA 2024 (including early bird deadlines), new research opportunities, and ways to get involved in our growing community.
Read more

New Study Explores Tunnel-Targeted Antimicrobial Gel for HS Treatment

July 11, 2025

A newly published prospective study in JAAD highlights a novel approach for treating Hidradenitis Suppurativa using a topical clindamycin gel delivered directly into tunnels. The treatment showed promising results in reducing inflammation, resolving tunnels, restoring microbial balance, and improving quality of life. Led by researchers at the University of Miami, including HSF President Dr. Hadar Lev-Tov, this work offers new insights into localized therapies for HS.
Read more

Dermatologic Procedures for Hidradenitis Suppurativa

July 10, 2025

Explore how dermatologic procedures like deroofing, excision, and laser therapies are helping patients with hidradenitis suppurativa achieve better outcomes. This article highlights expert insights on selecting the right approach based on severity, recurrence, and patient goals.
Read more

Efficacy and Safety of Medical Interventions for Moderate to Severe Hidradenitis Suppurativa

July 2, 2025

A newly published living systematic review and network meta-analysis in JAMA Dermatology offers an in-depth look at the current evidence on medical therapies for HS. This important research helps inform treatment decisions and highlights the growing momentum in HS clinical trials.
Read more

Best practice in the management of Hidradenitis Suppurativa lesions

July 1, 2025

Access the Best Practice in the Management of Hidradenitis Suppurativa Lesions—an international consensus document offering practical, evidence-informed guidance on diagnosing, assessing & managing HS lesions. Developed by a panel of wound care & dermatology experts, this resource covers cleansing, dressing selection, pain control, surgical options & more.
Read more

Spironolactone for Hidradenitis Suppurativa: A Game-Changer for Women of Childbearing Age?

June 30, 2025

Could spironolactone be a game-changer for women with early-stage HS? A recent study found that while only 1 in 5 women of childbearing age saw improvement with the hormone-blocking drug, those with milder disease and earlier treatment were far more likely to benefit. This research offers valuable insight into tailoring HS treatment for patients most likely to respond.
Read more

Deroofing – Safe and Effective for HS Patients

June 18, 2025

A new study highlights the safety and effectiveness of deroofing—a surgical treatment for hidradenitis suppurativa. Among 44 patients, only 12% of lesions returned within a year, and most reported less pain and better quality of life. While further research is needed, these results suggest deroofing may be a valuable option, even alongside systemic therapies.
Read more

Semaglutide for diabetes, weight loss, and… Hidradenitis Suppurativa?

April 28, 2025

Could a popular weight loss and diabetes drug also help treat hidradenitis suppurativa? See what researchers discovered about semaglutide’s surprising potential.
Read more

Incyte Announces Positive Topline Results From Two Phase 3 Clinical Trials of Povorcitinib in Patients With Hidradenitis Suppura

March 18, 2025

Incyte announced positive Phase 3 results for povorcitinib in hidradenitis suppurativa, with both trials meeting their primary endpoint of reducing inflammatory nodules.
Read more